October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
<a href="https://pixabay.com/users/mohamed_hassan/">mohamed_hassan</a> / Pixabay

October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease

An ongoing Phase 3 clinical trial program is investigating the drug PXT3003 as an experimental treatment for Charcot-Marie-Tooth disease type 1A in adults. Pharnext SA says that they expect to…

Continue Reading
  • 1
  • 2
Close Menu